Egil peter harvold
Egil Peter Harvold (1912 – November 17, 1992) was an American Orthodontist who is known for developing a Cephalometric analysis known as Harvold Analysis. He also is known to contribute significantly towards the understanding of the orofacial clefts and craniofacial development.[1][2]
Life[edit | edit source]
Dr. Harvold received his degrees in Medicine and Dentistry in Germany and Norway respectively. He practiced as an Orthodontist in 1937 in Norway. After few years of practicing Orthodontics, he received his Ph.D in Anatomy from Oslo, Norway. Because of his interested in Cleft Lip & Palate and other craniofacial anomalies, he became interested in becoming a research fellow at a dental institute in Oslo. He eventually came to University of Michigan for teaching for couple years. After then, he went to University of Toronto in 1959, where he became a Professor and Head of Orthodontic Department until 1961.
In 1963, he headed off to University of California, San Francisco where he became the Director of Center of Craniofacial Anomalies until his retirement in 1980. Dr. Harvold's research focused on interrelationship between genetic and environmental factors in development of head an face.[3]
He died in Oslo, Norway in 1992 at the age of 80.
Awards and positions[edit | edit source]
- The Royal College of Dentists of Canada Award
- University of Toronto & University of Wales, Honorary Degrees
- International Society of Craniofacial Biology, President
- Department of Medicine and Surgery, Veteran's Administration, Member
References[edit | edit source]
- ↑
- ↑ "University of California: In Memoriam, 1993". texts.cdlib.org. Retrieved 2015-12-25.
- ↑ "University of California: In Memoriam, 1993". texts.cdlib.org. Retrieved 2015-12-25.
Portions of content adapted from Wikipedia's article on Egil peter harvold which is released under the CC BY-SA 3.0.
 | This dentistry article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Bonnu
